logo
  

Pfizer To Provide 500 Mln Doses Of COVID-19 Vaccine To U.S. For Donation To Poorest Nations

Pfizer Inc. (PFE) and BioNTech SE (BNTX) plan to provide 500 million doses of their COVID-19 vaccine to U.S. government for donation to the poorest nations.

The U.S. government will purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first half of 2022.

The doses are part of Pfizer and BioNTech's previously announced pledge to provide two billion doses of the COVID-19 vaccine to low- and middle-income countries over the next 18 months.

As part of the plan, the United States will allocate the vaccine doses to 92 low- and lower middle-income countries and economies as defined by Gavi's COVAX Advance Market Commitment (AMC) and the 55 member states of the African Union.

Deliveries of the 200 million doses will begin in August 2021 and continue through the remainder of the year. The 300 million doses for 2022 will be delivered between January and end of June 2022. The U.S. government also has the option for additional doses in 2022.

To date, Pfizer and BioNTech have shipped 700 million doses to more than 100 countries or territories around the world. The companies have direct supply agreements in place with 122 countries and discussions are ongoing with many more on the supply of the companies' COVID-19 vaccine.

Based on current projections, Pfizer and BioNTech expect to manufacture up to 3 billion doses of the COVID-19 vaccine in 2021.

The Pfizer-BioNTech COVID-19 vaccine has been authorized for emergency use by U.S. Food and Drug Administration, under an Emergency Use Authorization to prevent Coronavirus Disease 2019 caused by SARS-CoV-2 for use in individuals 12 years of age and older.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting its financial results for the second quarter on Thursday, Kellogg Co. (K) reaffirmed its currency-neutral adjusted earnings growth guidance for the full year 2021. For fiscal 2021, the company now projects currency-neutral adjusted earnings per share growth of about 1 to 2 percent... Moderna Inc. (MRNA) reported a profit for the second quarter compared to a loss in the previous year, reflecting surging revenues on commercial sales of the company's COVID-19 vaccine in the U.S. Quarterly earnings per share and revenues topped analysts' expectations. The company raised its 2021 sales forecast for its COVID-19 vaccine. New Widetech has recalled dehumidifiers sold under various brand names citing fire and burn risks, the U.S. Consumer Product Safety Commission said. The brand names include AeonAir, Amana, Haier, Honeywell, and Whirlpool, among others. The recall was initiated after New Widetech received reports of 107 incidents of the recalled dehumidifiers overheating and/or catching fire.
Follow RTT